Misonix Names Sharon Klugewicz Chief Operating Officer
March 04 2019 - 8:00AM
Misonix, Inc. (Nasdaq: MSON) (“Misonix” or the “Company”), a
provider of minimally invasive therapeutic ultrasonic medical
devices that enhance clinical outcomes, today announced that Sharon
Klugewicz has been appointed Chief Operating Officer.
In this newly created position, Ms. Klugewicz
will oversee all aspects of manufacturing, regulatory affairs,
quality assurance and research & development. Her appointment
reflects Misonix’s focus on driving operational excellence across
the business to support accelerating demand for its leading
ultrasonic products, while advancing the Company’s goals for
continued growth and the enhancement of shareholder value. Ms.
Klugewicz will report to Stavros Vizirgianakis, President and CEO
of Misonix.
Stavros Vizirgianakis, President and Chief
Executive Officer of Misonix stated, “In the first half of fiscal
2019, we undertook a range of initiatives focused on reducing
inefficiencies across the business to best position Misonix for the
future. We created the Chief Operating Officer position to
accelerate the execution of our growth strategy following the
successful alignment of our operating infrastructure earlier this
year, and are extremely fortunate to have retained an industry
executive with Sharon’s extensive record of accomplishments. Sharon
brings a wealth of experience that will enhance our ability to
execute on our growth strategy as we bring new solutions to market,
expand into new geographies, address an increasing number of
medical procedures and further leverage our in-house sales team and
R&D capabilities. We are confident that Sharon’s operational
expertise and business acumen will help ensure that we achieve our
goals for sustainable revenue growth and profitability, and that
our efforts yield the best possible outcomes for our
shareholders.”
Most recently, Ms. Klugewicz served as Chief
Quality & Regulatory Affairs Officer at Chembio Diagnostics
Systems, as well as President of the Americas, and Chief Operating
Officer. During her tenure, Ms. Klugewicz played a critical role in
the company’s operational and commercial success, including
manufacturing expansion and bringing new products to market. Prior,
Ms. Klugewicz spent over twenty years at Pall Corporation, where
she served as Sr. Vice President of Global Scientific &
Laboratory Services, responsible for the efficient and profitable
service delivery of the company’s products and solutions, and as
SVP of Global Quality Assurance & Regulatory Compliance of the
Life Sciences division, leading regulatory and quality assurance
activities across multiple manufacturing sites to support
operational efficiency and compliance.
Ms. Klugewicz received a Bachelor of Science
degree in Neurobiology from Stony Brook University and obtained a
Master of Science in Biochemistry from Adelphi University. She has
been a featured speaker at various industry events and is involved
in various committees, including the Women in Science &
Engineering Committee at Stony Brook University.
Ms. Klugewicz commented, “I am very excited at
the opportunity to join Misonix and to be part of a fast-growing
company that is leveraging its unique proprietary ultrasonic
technology to bring to market medical devices that deliver
demonstrated clinical benefits and improve patient outcomes. I look
forward to utilizing my range of skills, knowledge and experiences
gained across the industry to promote innovation, improved
productivity, team building and organizational success, while
supporting Misonix’s business goals. I look forward to working with
the Board and the Misonix team to lead the company to its next
phase of growth and success.”
About Misonix, Inc.
Misonix, Inc. (NASDAQ: MSON) designs,
manufactures and markets ultrasonic medical devices for the precise
removal of hard and soft tissue, including bone removal, wound
debridement and ultrasonic aspiration. Misonix is focused on
leveraging its proprietary ultrasonic technology to become the
standard of care in operating rooms and clinics around the world.
Misonix's proprietary ultrasonic medical devices are used in a
growing number of medical procedures, including spine surgery,
neurosurgery, orthopedic surgery, cosmetic surgery, laparoscopic
surgery, and other surgical and medical applications. At Misonix,
Better Matters to us. That is why throughout the Company’s history,
Misonix has maintained its commitment to medical technology
innovation and the development of ultrasonic surgical products that
radically improve patient outcomes. Additional information is
available on the Company's web site at www.misonix.com.
Contact: |
|
Joe Dwyer |
Joseph Jaffoni, Norberto
Aja, Jennifer Neuman |
Chief Financial
Officer |
JCIR |
Misonix, Inc. |
212-835-8500 or
mson@jcir.com |
631-927-9113 |
|
Misonix (NASDAQ:MSON)
Historical Stock Chart
From Mar 2024 to Apr 2024
Misonix (NASDAQ:MSON)
Historical Stock Chart
From Apr 2023 to Apr 2024